Sanofi is buying an immunology drug from Dren Bio, Inc. for up to $1.9 billion, in a deal it said will help it become a ...

Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field.

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...

French pharma major Sanofi (Euronext: SAN) today revealed it has entered into a definitive agreement with privately-held US biotech Dren Bio, to acquire the latter’s DR-0201, a targeted bispecific ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to ...

Drinks maker Refresco shelved a €2.1 billion ($2.3 billion) leveraged loan repricing on Thursday, as sentiment sours among ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, ...

Saskatchewan Blue Cross has contributed a $25,000 donation to the Z99 Radiothon, helping provide life-saving care for newborns in the Neonatal Care Unit (NICU) through the Hospitals of Regina ...

British home improvement retailer Wickes reported a 16% fall in annual adjusted pre-tax profit on Thursday, as economic woes prompted consumers to cut back on their discretionary spending.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

The government has identified life sciences as one of the sectors with the highest potential for growth in the UK and plans to make it a key pillar of its upcoming industry strategy. The ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.